Pay in 4 interest-free payments of $5.78 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
The c-MET serves as an attractive therapeutic target in SCLC, as shown through small interfering RNA (siRNA) and selective prototype c-MET inhibitor SU11274, inhibiting the phosphorylation of c-MET itself and its downstream molecules such as AKT, S6 kinase, and ERK1/2
eLife 9 , e53518 (2020)
Storage and Handling Information GHK-Cu should be stored according to the product specification, with 4C used as the primary reference from the PeptideLabs catalog data
Crediting the combinations performance to cagrilintide alone overstates the monotherapy evidence
Enhancing Metabolic Health: Insulin Resistance & Fat Loss One of the most well-documented MOTS-c benefits is its profound impact on metabolic function
US$ 24.91
US$ 23.09
US$ 22.31
US$ 22.25
US$ 25.82
US$ 20.34
